Concepedia

Vivek Subbiah

VS

301

Publications

24.1K

Citations

69

H-Index

2007

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Massachusetts General Hospital

Institut Gustave Roussy

Memorial Sloan Kettering Cancer Center

Sarah Cannon

Vivek Subbiah is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2007–2025

301

Publications

301

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

, , +11

Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations

David M. Hyman, Igor Puzanov, Vivek Subbiah et al. · New England Journal of Medicine · 2015 · 1.7K citations · Full text

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic <i>BRAF</i> V600–Mutant Anaplastic Thyroid Cancer

Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg et al. · Journal of Clinical Oncology · 2017 · 848 citations · Full text

, , +15

Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan et al. · New England Journal of Medicine · 2020 · 810 citations · Full text

Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers

Lori J. Wirth, Eric J. Sherman, Bruce Robinson et al. · New England Journal of Medicine · 2020 · 731 citations · Full text

Rows per page

1–5 of 301